OKYO · NASDAQ · Biotechnology

OKYO Pharma (OKYO)

Develops urcosimod eye drops for neuropathic corneal pain and anterior-segment eye diseases.

$1.36
vs last close+0.01 (+0.74%)
  1. What Makes OKYO Pharma (OKYO) a New Buy Stock

    Zacks Investment Research